June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...
Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists discuss how first-generation antipsychotics primarily manage positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results